Google DeepMind Releases AlphaGenome 2 to Predict Cell-State Variant Effects

At a glance

Google DeepMind released AlphaGenome 2 on November 11, 2026. The AI model predicts how DNA variants affect gene regulation in different cell types and states. It is free for non-commercial research, while commercial use is in private preview.

Key points

1. 1

   It was trained on more than 100 million individual cell profiles.

2. 2

   By taking cell type and state as conditions, it shows how the same DNA can be read differently in different cells.

3. 3

   It was used in case studies on inflammatory bowel disease and COVID-19 mRNA vaccine research to find disease-linked variants.

4. 4

   The paper warns that the model mostly captures correlation rather than causation, and it is not validated for clinical or diagnostic use.

Why it matters

The same genetic variant can affect disease differently depending on which cells it is active in. The model helps researchers narrow down candidate variants, but its results still need to be confirmed through experiments.

Also reported by

• The VergeGoogle’s AlphaGenome 2 zooms in on the cellular roots of disease
• Google DeepMind blogAlphaGenome 2: Deciphering how cells read DNA to better understand disease
• 사이언스모니터구글 딥마인드 ‘알파게놈 2’ 공개…유형별 DNA 변이 효과 예측
• DongA Science1년 반 걸리는 실험 30분 만에…구글 딥마인드, '알파게놈2' 공개